Safety Study of Grass Pollen-derived Peptides to Treat Seasonal Allergic Rhinoconjunctivitis

NCT00833066 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Rhinoconjunctivitis

Interventions

BIOLOGICAL: gpASIT+TM
BIOLOGICAL: Placebo
BIOLOGICAL: gpASIT+TM
BIOLOGICAL: gpASIT+TM

Sponsor

BioTech Tools S.A.